• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“一步法”乳化制备多孔 PLGA 微球用于肺部给药:表面形态和空气动力学性质。

Porous PLGA microparticles formed by "one-step" emulsification for pulmonary drug delivery: The surface morphology and the aerodynamic properties.

机构信息

Department of Organic and Polymer Materials Chemistry, Faculty of Engineering, Tokyo University of Agriculture and Technology, Japan.

Department of Organic and Polymer Materials Chemistry, Faculty of Engineering, Tokyo University of Agriculture and Technology, Japan.

出版信息

Colloids Surf B Biointerfaces. 2017 Nov 1;159:318-326. doi: 10.1016/j.colsurfb.2017.08.004. Epub 2017 Aug 4.

DOI:10.1016/j.colsurfb.2017.08.004
PMID:28806664
Abstract

In the present study, by using a newly developed one-step emulsification technique, we tried to prepare porous PLGA particles having a proper diameter and surface morphology in order to achieve both a high efficient delivery of the particles to the lungs and a phagocytosis-avoidance ability. We found that our porous particles have the very low tapped density of 0.04g/cm. Experimental and theoretical studies strongly suggest that the shape factor should not be determined only by the outline of the particles, although previous research assigned a value of 1 to the shape factor for particles regardless of the presence of pores and their distribution. We found the possibility that our porous particles both had specific internal structures induced by spontaneous emulsification and exhibited unusual aerodynamic performance.

摘要

在本研究中,我们采用新开发的一步乳化技术,尝试制备具有适当粒径和表面形态的多孔 PLGA 颗粒,以实现颗粒向肺部的高效传递和吞噬避免能力。我们发现我们的多孔颗粒具有非常低的振实密度为 0.04g/cm³。实验和理论研究强烈表明,形状因子不应仅由颗粒的轮廓决定,尽管以前的研究将形状因子的值分配给了无论是否存在孔及其分布的颗粒。我们发现,我们的多孔颗粒可能具有由自发乳化引起的特定内部结构,并表现出异常的空气动力学性能。

相似文献

1
Porous PLGA microparticles formed by "one-step" emulsification for pulmonary drug delivery: The surface morphology and the aerodynamic properties.“一步法”乳化制备多孔 PLGA 微球用于肺部给药:表面形态和空气动力学性质。
Colloids Surf B Biointerfaces. 2017 Nov 1;159:318-326. doi: 10.1016/j.colsurfb.2017.08.004. Epub 2017 Aug 4.
2
Development of highly porous large PLGA microparticles for pulmonary drug delivery.用于肺部给药的高度多孔大尺寸聚乳酸-羟基乙酸共聚物微粒的研发
Biomaterials. 2009 Apr;30(10):1947-53. doi: 10.1016/j.biomaterials.2008.12.044. Epub 2009 Jan 8.
3
Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.具有改善雾化特性的载胰岛素聚乳酸-羟基乙酸共聚物/环糊精大孔颗粒:经大鼠肺部给药后的体内沉积及降血糖活性
J Control Release. 2009 Apr 2;135(1):25-34. doi: 10.1016/j.jconrel.2008.12.011. Epub 2008 Dec 25.
4
Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.聚乳酸-共-羟基乙酸共聚物微球作为重组人白细胞介素-2肺部给药载体的制备和评价:Ⅱ.干粉吸入剂配方的空气动力学性质的体外研究。
Drug Dev Ind Pharm. 2011 Nov;37(11):1376-86. doi: 10.3109/03639045.2011.576680. Epub 2011 May 6.
5
Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.蛋白质药物的微囊化给药:策略、制备及应用。
J Control Release. 2014 Nov 10;193:324-40. doi: 10.1016/j.jconrel.2014.09.003. Epub 2014 Sep 10.
6
One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.使用四流体喷嘴喷雾干燥器一步制备含利福平/聚乳酸-羟基乙酸共聚物纳米颗粒的甘露醇微球用于肺结核吸入治疗
J Control Release. 2009 Apr 2;135(1):19-24. doi: 10.1016/j.jconrel.2008.11.027. Epub 2008 Dec 7.
7
Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.表面活性剂的选择对用于肺部药物递送的微粒制剂及特性的影响。
Drug Dev Ind Pharm. 2015 Mar;41(3):522-8. doi: 10.3109/03639045.2014.884117. Epub 2014 Mar 20.
8
Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.探索聚乙烯吡咯烷酮在通过单乳液法工程大孔 PLGA 微球中的应用,以实现肺部的可调节持续释放:体外和体内特性研究。
J Control Release. 2017 Mar 10;249:11-22. doi: 10.1016/j.jconrel.2017.01.023. Epub 2017 Jan 18.
9
Albumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetes.棕榈酰化艾塞那肽结合白蛋白包覆多孔聚乳酸-羟基乙酸共聚物微球作为长效吸入递药系统用于治疗糖尿病
Pharm Res. 2011 Aug;28(8):2008-19. doi: 10.1007/s11095-011-0427-4. Epub 2011 Apr 7.
10
Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.采用渗透压剂控制聚合物微球的多孔结构用于肺部给药。
J Control Release. 2010 Aug 17;146(1):61-7. doi: 10.1016/j.jconrel.2010.05.026. Epub 2010 May 26.

引用本文的文献

1
Inhalable Nanomaterial Discoveries for Lung Cancer Therapy: A Review.用于肺癌治疗的可吸入纳米材料研究进展:综述
Pharmaceutics. 2025 Jul 31;17(8):996. doi: 10.3390/pharmaceutics17080996.
2
PLGA-Based Strategies for Intranasal and Pulmonary Applications.基于聚乳酸-羟基乙酸共聚物的鼻内和肺部应用策略。
Pharmaceutics. 2025 Feb 6;17(2):207. doi: 10.3390/pharmaceutics17020207.
3
Drug-Eluting Porous Embolic Microspheres for Trans-Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer.载药多孔栓塞微球经动脉途径递送至肝癌的双重协同抗癌治疗。
Adv Healthc Mater. 2023 Dec;12(30):e2301548. doi: 10.1002/adhm.202301548. Epub 2023 Jun 26.
4
Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations.可吸入微粒作为干粉制剂中肺部给药系统。
Regen Biomater. 2022 Dec 8;10:rbac099. doi: 10.1093/rb/rbac099. eCollection 2023.
5
Fabrication and characterization of novel macroporous hydrogels based on the polymerizable surfactant AAc-Span80 and their enhanced drug-delivery capacity.基于可聚合表面活性剂AAc-Span80的新型大孔水凝胶的制备与表征及其增强的药物递送能力。
RSC Adv. 2022 Oct 18;12(46):29677-29687. doi: 10.1039/d2ra02443h. eCollection 2022 Oct 17.
6
Temperature-Responsive Polysaccharide Microparticles Containing Nanoparticles: Release of Multiple Cationic/Anionic Compounds.含纳米颗粒的温度响应性多糖微粒:多种阳离子/阴离子化合物的释放
Materials (Basel). 2022 Jul 5;15(13):4717. doi: 10.3390/ma15134717.
7
Hyaluronic Acid Hydrogels for Controlled Pulmonary Drug Delivery-A Particle Engineering Approach.用于肺部药物控释的透明质酸水凝胶——一种颗粒工程方法
Pharmaceutics. 2021 Nov 5;13(11):1878. doi: 10.3390/pharmaceutics13111878.
8
Recent advances in the formulation of PLGA microparticles for controlled drug delivery.用于控释给药的聚乳酸-羟基乙酸共聚物(PLGA)微粒制剂的最新进展。
Prog Biomater. 2020 Dec;9(4):153-174. doi: 10.1007/s40204-020-00139-y. Epub 2020 Oct 15.
9
Exploring Drug Treatment Patterns Based on the Action of Drug and Multilayer Network Model.基于药物作用和多层网络模型探索药物治疗模式。
Int J Mol Sci. 2020 Jul 16;21(14):5014. doi: 10.3390/ijms21145014.
10
PLA- and PLA/PLGA-Emulsion Composite Biomaterial Sheets for the Controllable Sustained Release of Hydrophilic Compounds.用于亲水性化合物可控缓释的聚乳酸及聚乳酸/聚乙醇酸共聚物乳液复合生物材料片材
Materials (Basel). 2018 Dec 19;11(12):2588. doi: 10.3390/ma11122588.